Tarveda Therapeutics Inc. a clinical stage biopharmaceutical company discovering and developing Pentarins as a new class of potent and selective medicines to treat a wide range of cancers today announced that Drew Fromkin Pres...

Advaxis Inc.ÂNASDAQADXS a latestage biotechnology company focused on the discovery development and commercialization of immunotherapy products announced today the upcoming release of financial results for the six months ended ...

Designation Recognizes Commitment to Exemplary Care and Optimal Patient Outcomes with New TreatmentDAVENPORT Fla. PRWEB May 31 2018 Boardcertified urologist Michael DAngelo M.D. with Heart of Florida Physician Group announced today he has been designated ...

GTx Inc. Nasdaq GTXI today announced that Robert J. Wills PhD Executive Chairman will present a company overview at the Jefferies 2018 Global Healthcare Conference on Thursday June 7 2018 at 1000 am ET in New York. A si...

A free PSA test measures the level of prostatespecific antigens that are not bound to other proteins in the blood. This test can help doctors to diagnose problems with the prostate including cancer. In this article we look at how a free PSA test differs fr...

Elsevier A new study published in The Journal of Urology reports that men with prostate cancer who had worse urinary bowel and sexual function after surgery or radiotherapy than others experienced more emotional distress. Interestingly the reverse was also...

NEW YORK May 31 2018 GLOBE NEWSWIRE Progenics Pharmaceuticals Inc. NasdaqPGNX an oncology company developing innovative medicines and imaging technology for targeting and treating cancer announced today that an abstract describing the Companys imaging a...

Following significant scientific and clinical treatment advances in recent years the Society for Immunotherapy of Cancer SITC updated its firstofitskind evidencebased consensus statement on tumor immunotherapy for the treatment of cutaneous melanoma. The u...

Expansive clinical research and realworld evidence data to be presented on prostate cancer genome sequencing melanoma bladder cancer metastatic breast cancer and more McKesson Specialty Health announced today that oncologists fro...

Treating prostate cancer could one day be as noninvasive as inhaling certain scented compounds. The idea may not be as farfetched as it sounds given that new research from investigators at Duke University School of Medicine shows that an olfactory receptor...

Could a long noncoding RNA that has a role in androgen receptor signaling in prostate cancer be a treatment target that does not lead to resistance

A new blood test for determination of prostate cancer risk was found to be more accurate than the current gold...

NewsResearchers at the University of Michigan Rogel Cancer Center identified a novel gene they named ARLNC1 which controls signals from the androgen receptor a key player in prostate cancer.

How do these risk calculators for predicting prostate biopsy outcome compare in terms of sensitivity and specificity Translational Andrology and Urology

Tarveda Therapeutics Inc. a clinical stage biopharmaceutical company discovering and developing Pentarins as a new class of potent and selective medicines to treat a wide range of cancers today announced that Drew Fromkin Pres...

Companys growth supports upcoming clinical programs to help better predict patient response to oncology drugs before treatment begins KIYATEC Inc. a privately held company changing the future of cancer care by predicting pa...

Studies of Inhaled NanoPac Show Prolonged Retention in the Lung Decreased Primitive Tumor cells and Increased Tumor Regression NanOlogy LLC a clinicalstage pharmaceutical development company will present dat...